Top Clinical Trials companies in Australia by Free Cash Flow Yield

This ranking features the top 10 Clinical Trials companies in Australia ranked by Free Cash Flow Yield, averaging a Free Cash Flow Yield of 1.85%, for February 07, 2025.
#
Name
Free Cash Flow Yield
Reported Date
Stock Price
Change
Price (30 days) Country
1

22.00%

Feb. 5, 2025 USD 2.33 0.08%

Australia

2

7.24%

Feb. 5, 2025 USD 0.74 0.62%

Australia

3

5.76%

Feb. 5, 2025 USD 7.27 0.71%

Australia

4

3.74%

Feb. 5, 2025 USD 0.74 1.48%

Australia

5

1.82%

Feb. 5, 2025 USD 169.95 -0.56%

Australia

6

0.15%

Feb. 5, 2025 USD 18.33 -0.84%

Australia

7

0.06%

Feb. 5, 2025 USD 1.23 -0.40%

Australia

8

-2.08%

Feb. 5, 2025 USD 1.90 -4.74%

Australia

9

-3.81%

Feb. 5, 2025 USD 2.46 10.79%

Australia

10

-16.38%

Feb. 5, 2025 USD 6.16 2.82%

Australia

Frequently Asked Questions
  • Which Clinical Trials company in Australia has the highest Free Cash Flow Yield ?

    The Clinical Trials company in Australia with the highest Free Cash Flow Yield is Australian Clinical Labs Limited (ASX: ACL.AX) at 22.00%.

  • Which Clinical Trials company in Australia has the lowest Free Cash Flow Yield ?

    The Clinical Trials company in Australia with the lowest Free Cash Flow Yield is Anteris Technologies Ltd (ASX: AVR.AX) at -16.38%.

SV Wall Street